ArticleFrontiers in pharmacology2023

Cardiovascular risk of Janus kinase inhibitors compared with biologic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis without underlying cardiovascular diseases: a nationwide cohort study.

Yun-Kyoung Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.